Work

A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e15017

Authors: Yelena Yuriy Janjigian, Marinela Capanu, Christopher M. Gromisch, David Paul Kelsen, Geoffrey Y. Ku, Karen T. Brown, Mark Schattner, David H. Ilson, David B. Solit, Michael F. Berger, Efsevia Vakiani

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4233203289

Cites:

Cited by: 3

Related to: 10